CORMORANT ASSET MANAGEMENT, LP – Ambrx Biopharma Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$2.52M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-59.25%
quarter
Ambrx Biopharma Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.03% | -149.99K shares | -4.06M | $1.08 | 2.33M |
| Q2 2022 | share | 0.00% | 0 shares | -3.65M | $2.65 | 2.48M | |
| Q1 2022 | share | 0.00% | 0 shares | -12.20M | $4.12 | 2.48M | |
| Q4 2021 | share | 0.00% | 0 shares | -10.64M | $9 | 2.48M | |
| Q3 2021 | share | 0.00% | 0 shares | -13.93M | $13.5 | 2.48M | |
| Q2 2021 | share | Increase | 0.00% | 2.48M shares | 47.03M | $19.6 | 2.48M |